Peer-Reviewed Publications

    Optimization of a novel in situ hybridization technology on 3D organotypic cell cultures

    Neau, L.; Lorin, C.; Frentzel, S.; Hoeng, J.; Iskandar, A.; Leroy, P.; Trivedi, K.
    Published
    Feb 27, 2019
    DOI
    10.1089/aivt.2018.0021
    Link to publication
    Topic
    Summary

    Introduction: Developed by Advanced Cell Diagnostics, RNAscope® in situ hybridization technology enables detection of a target RNA in a cell-specific manner on formalin-fixed paraffin-embedded tissue sections and represents a good alternative to immunohistochemistry. The goal of this work is to illustrate an optimized protocol of the RNAscope technology to detect target genes in various human organotypic culture models (nasal, small airway, and gingival). These culture models retain the three-dimensional structure of native epithelium, mimic in vivo morphology and human physiology, and can be used as alternative sources to animal testing. Materials and Methods: After fixation and processing of five replicates of the three different organotypic cell cultures, the tissue morphology was checked by hematoxylin and eosin staining. The RNAscope protocols were optimized based on three crucial parameters: heat pretreatment, enzymatic digestion, and signal amplification. Digital images of the RNAscope stained slides were generated using the Hamamatsu NanoZoomer 2.0 slide scanner, and images were quantified using a custom-made plugin on Definiens Tissue Studio software (Definiens AG, Munich, Germany). Results: The tissue morphology demonstrates optimum fixation and processing for samples, while the optimized protocol for RNAscope shows preserved RNA with staining on the positive control probe with score ≥2 and no staining on the negative control probe with score <1. Discussion and Conclusion: RNAscope combined with organotypic cell cultures is a promising tool to better understand cell-specific RNA expression while implementing 3R (replace, reduce, and refine animal testing) principles.

    Related Publications

    The response of human nasal and bronchial organotypic tissue cultures to repeated whole cigarette smoke exposure

    Pre-clinical Toxicology Systems Toxicology

    Mechanism of an indirect effect of aqueous cigarette smoke extract on the adhesion of monocytic cells to endothelial cells in an in vitro assay revealed by transcriptomics analysis

    Pre-clinical Toxicology Systems Toxicology

    Modeling early initiation processes in smoking-induced lung adenocarcinomas

    Pre-clinical Toxicology Systems Toxicology

    Impact of cigarette smoke and Modified Risk Tobacco Products (MRTPs) on DNA methylation

    Pre-clinical Toxicology Systems Toxicology

    Quantitative proteomics analysis using 2D-PAGE to investigate the effects of cigarette smoke and aerosol of a prototypic modified risk tobacco product on the lung proteome in C57BL/6 mice

    Pre-clinical Toxicology Systems Toxicology

    Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis

    Pre-clinical Toxicology Systems Toxicology

    The response of human nasal and bronchial organotypic tissue cultures to repeated whole cigarette smoke exposure

    Pre-clinical Toxicology Systems Toxicology

    Mechanism of an indirect effect of aqueous cigarette smoke extract on the adhesion of monocytic cells to endothelial cells in an in vitro assay revealed by transcriptomics analysis

    Pre-clinical Toxicology Systems Toxicology

    Modeling early initiation processes in smoking-induced lung adenocarcinomas

    Pre-clinical Toxicology Systems Toxicology

    Impact of cigarette smoke and Modified Risk Tobacco Products (MRTPs) on DNA methylation

    Pre-clinical Toxicology Systems Toxicology

    Quantitative proteomics analysis using 2D-PAGE to investigate the effects of cigarette smoke and aerosol of a prototypic modified risk tobacco product on the lung proteome in C57BL/6 mice

    Pre-clinical Toxicology Systems Toxicology

    Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis

    Pre-clinical Toxicology Systems Toxicology

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.